Table 1. Demographic and baseline ECG characteristics of patients who received sotalol.
Discovery cohort | Replication cohort | Pvalue | |
---|---|---|---|
Subjects who received sotalol | 495 | 495 | ns |
Age (years) | 29±10.8 | 28±10.2 | ns |
Female (%) | 311(63%) | 303(61%) | ns |
Kalemia (mmol/l) | 4±0.3 | 4.1±0.3 | <0.001 |
Plasma sotalol at H3 (ng/ml) | 398±134 | 448±153 | <0.001 |
European / North-African | 448 (90%)/47(10%) | 431(87%) / 64(13%) | ns |
Baseline QTcF (mean±SD), msec | 389±17 | 387±17 | 0.02 |
Baseline QTcF (median,[IQR]), msec | 388 [374; 398] | 389 [377; 399] | 0.03 |
Baseline QTcF (Min; Max), msec | 333; 432 | 333; 439 | |
Baseline RR (mean±SD), msec | 905±115 | 907±102 | ns |
Baseline TAmp (mean±SD), mV | 512±177 | 531±183 | ns |
Baseline TpTe (mean±SD), msec | 70±9 | 67±9 | <0.001 |
Baseline Notching (%) | 0(0%) | 0(0%) | ns |
ns represents p>0.05. Mean ± standard deviation and median [interquartile range] are shown.